On the evening of January 30, A-share listed companies intensively disclosed their 2023 performance forecasts, among which Hengyu Information Communication (300965), Science and Technology Innovation, Zhijiang Biotechnology and other shares suffered losses. At the opening of the market on January 31, the above-mentioned pre-loss stocks appeared in a large area, including Hengyu Information Communication, Qingdao Zhongcheng and other shares of "20cm" down limit. In addition, after a reporter from Beijing Business Daily, Haitian Ruisheng, Mingguan New Materials, Zhijiang Biotechnology, Dongyue Silicon Materials and other shares may usher in the first loss after listing.
The stock price of many pre-loss stocks fell sharply.
As soon as the announcement of the 2023 performance loss was disclosed, the stock prices of many shares such as Keda Innovation and Qingdao Zhongcheng were voted by investors "with their feet" on January 31.
On January 31, Hengyu Information Communication, Qingdao Zhongcheng, Sanfu New Materials, *ST Zuojiang, Xinning Logistics, *ST Hongxiang, *ST Tianshan, Keda Innovation, Haitian Ruisheng, Ren Zixing, Huaru Technology, Polytechnic Navigation and other stocks fell first, including Hengyu Information Communication, Qingdao Zhongcheng, Sanfu New Materials, *ST Zuojiang, Xinning Logistics, *ST Hongxiang and other 6 shares "20cm" down limit.
Looking at the above sharp declines**, most of them disclosed the company's 2023 performance forecast on the evening of January 30, and the annual net profit is expected to be a loss. For example, Hengyu Information Communication expects the company to achieve attributable net profit of -1 in 2023$8.5 billion to -10.5 billion yuan; Qingdao Zhongcheng expects to achieve attributable net profit of -10 in 20237.8 billion yuan to -7700 million yuan; Sanfu New Materials expects to achieve attributable net profit of -41.5 million yuan to -34.5 million yuan in 2023.
In addition to the negative performance of ST Zuojiang, the company was also notified by the China Securities Regulatory Commission that it was suspected of major financial fraud. On the evening of January 30, the official website of the China Securities Regulatory Commission issued a document stating that after preliminary investigation, the financial information disclosed by *ST Zuojiang in 2023 was seriously untrue and suspected of major financial fraud.
Late at night on January 30, *ST Zuojiang disclosed the performance forecast and resumption announcement, and the company expects to achieve attributable net profit of -2 in 2023$2.5 billion to -1600 million yuan.
The trading ** shows that *ST Zuojiang opened on January 31 with a down limit, and ** reported a down limit price of 42 on the same day42 yuan shares, with a total market capitalization of 43$2.8 billion.
Although the number of science and technology innovations, Haitian Ruisheng, Ren Zixing, Huaru Technology, and Polytechnic Navigation did not fall to the limit, the company's stock price also suffered a heavy blow. Among them, the big science and technology technology closed down 15 on January 3186%, and the stock price was at 1422 yuan shares, with a total market capitalization of 41400 million yuan.
It is understood that the company landed in the A** field in July 2016, and the company is committed to creating intelligent products with integrated software and hardware, and providing overall IT solutions and digital operation services based on the cloud platform. On the evening of January 30, the company disclosed that the company expects to achieve an attributable net profit of about -3 in 2023900 million to -300 million yuan.
It is worth mentioning that in 2022, there will be a loss in the net profit of the University of Science and Technology, and the attributable net profit of the year will be about -57.87 million yuan, which also means that the net profit loss of the University of Science and Technology will occur for two consecutive years.
Similar to science and technology innovation, Huijin shares will also have a net profit loss. On January 31, Huijin shares closed down 1081%, and the stock price was at 5$94 shares. On the evening of January 30, Huijin shares disclosed that the company expects to achieve an attributable net profit of about -2 in 2023$4.3 billion to -16.2 billion yuan.
In 2022, the attributable net profit of Huijin shares will also be in a loss state, and the attributable net profit will be about -2 in that year8.2 billion yuan.
Zhijiang Biology and other departments suffered their first losses after listing.
According to the Beijing Business Daily reporter, in the above-mentioned sharp decline, Haitian Ruisheng, Mingguan New Materials, Zhijiang Biotechnology, Dongyue Silicon Materials and other stocks will usher in the first loss after listing.
Among them, the share price of Zhijiang Biotechnology fell by 10 on January 3154% when**1537 yuan shares, with a total market capitalization of 299.3 billion yuan. On the evening of January 30, Zhijiang Biotech disclosed that the company expects to achieve an attributable net profit of about -1 in 2023400 million to -100 million yuan; It is expected to achieve attributable net profit after deducting non-profits of about -1600 million to -1200 million yuan.
As for the reasons for the change in the company's performance, Zhijiang Biology said that during the reporting period, affected by changes in market demand, the sales revenue of the company's independent molecular diagnostic reagent products and instruments and equipment declined sharply, and at the same time, the company made provisions for the decline in the price of relevant inventories based on the principle of prudence in accordance with the relevant provisions of the accounting standards for enterprises and the company's accounting policies, which led to a year-on-year decline in operating income and net profit.
According to the data, Zhijiang Biology landed on the A** field in January 2021, and the company focuses on the research and development, production and sales of molecular diagnostic reagents and instruments and equipment. In 2021 and 2022, Zhijiang Biotech will be profitable, and the attributable net profit will be about 75.9 billion yuan, 7600 million yuan.
In 2023, the net profit is expected to be lost, and Zhijiang Bio will also usher in the first loss after listing. In response to related questions, a reporter from Beijing Business Daily called the office of the secretary of the board of directors of Zhijiang Biology for an interview, but no one answered.
In addition, Mingguan New Materials is expected to achieve attributable net profit of -22 million yuan to -16 million yuan in 2023, the company will land on the A** field in December 2020, and the company will also be profitable from 2020 to 2022.
Haitian AAC is mainly engaged in the R&D, design, production and sales of AI training data, and the company's net profit loss in 2023 will also become the company's first loss after listing. Dongyue Silicon expects the company to achieve attributable net profit of about -3 in 2023300 million yuan to -2700 million yuan, on January 31, the company's share price closed down 1113% to 663 yuan share.
It is understood that Dongyue Silicon will land in the A** field in March 2020, and the company is mainly engaged in the research and development, production and sales of organic silicon materials.
Bu Naxin, vice president of the Science and Technology Industry Investment Branch of the China International Association for the Promotion of Science and Technology and executive director of the strategic investment think tank, told the Beijing Business Daily reporter that the stock price performance of listed companies in the secondary market mainly depends on fundamentals, and the company's performance has declined sharply or turned into a loss, which will directly affect the company's stock price, which is also a rational judgment made by investors. "If a listed company wants to increase the company's stock price and market value, it is still necessary to start from the company's business and improve the company's profitability. Wang Chikun, an independent economist, said.
On January 31, Yang Delong, chief economist of Qianhai Open Source, also said that as the cornerstone of the capital market, improving the quality of listed companies is the key to improving the investability of the capital market, and the high-quality development of listed companies helps the high-quality development of the economy. In the view of Xu Xiaoheng, an investment and financing expert, the profitability of listed companies is also one of the important indicators that reflect the quality of listed companies.
Beijing Business Daily reporter Ma Changchang.